Bacteriophages as drivers of evolution : an evolutionary ecological perspective / / Stephen T. Abedon |
Autore | Abedon Stephen T. |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (382 pages) |
Disciplina | 160.5 |
Soggetto topico |
Bacteria - Evolution
Bacteriòfags Evolució (Biologia) |
Soggetto genere / forma | Llibres electrònics |
ISBN |
9783030943097
9783030943080 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910574095003321 |
Abedon Stephen T.
![]() |
||
Cham, Switzerland : , : Springer, , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Biocommunication of phages / / edited by Guenther Witzany |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (499 pages) |
Disciplina | 579.26 |
Soggetto topico |
Bacteriophages
Communication in biology Bacteriòfags Microbiologia |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-45885-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. What Does Communication of Phages Mean? -- Chapter 2. Phage-Phage, Phage-Bacteria, and Phage-Environment Communication -- Chapter 3. Phage communication and the ecological implications on microbial interactions, diversity, and function -- Chapter 4. Phage-Phage Interactions -- Chapter 5. Social interactions among bacteriophages -- Chapter 6. Phage protein interactions in the inhibition mechanism of bacterial cell -- Chapter 7. Are phages parasites or symbionts of bacteria? -- Chapter 8. Microbial communication networks: sketching a methodology to analyze communication involving bacteriophages inside environmental communities -- Chapter 9. Information stored in a phage particle: Lactobacillus delbrueckii bacteriophage LL-H as a case -- Chapter 10. Archaeal viruses and their interactions with CRISPR-Cas systems -- Chapter 11. Filamentous phages affect virulence of the phytopathogen Ralstonia solanacearum -- Chapter 12. Intra-population interactions and the evolution of RNA phages -- Chapter 13. ssRNA phages: life cycle, structure and applications -- Chapter 14. Phages as therapy or "dietary supplements"against multiresistant bacteria? -- Chapter 15. Bacteriophage application and biological safety (or how should I train my dog not to bite me) -- Chapter 16. Phage therapy: an alternative to antibiotics -- Chapter 17. Bacteriophage as a therapeutic agent to combat bacterial infection: A journey from history to application -- Chapter 18. Phagetherapy: Clinical applications – Critical appraisal of randomized controlled trials -- Chapter 19. Bacteriophage therapies targets multiple diseases caused by protein misfolding -- Chapter 20 -- Phage Therapy in Cystic Fibrosis. Challenges and Perspectives -- Chapter 21. Bacteriophage Applications for Food Safety -- Chapter 22. Bacteriophages for environmental applications: Effect of trans-organismic communication on wastewater treatments. |
Record Nr. | UNINA-9910409687503321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Phage Therapy: A Practical Approach / / edited by Andrzej Górski, Ryszard Międzybrodzki, Jan Borysowski |
Edizione | [1st ed. 2019.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
Descrizione fisica | 1 online resource (384 pages) |
Disciplina | 579.26 |
Soggetto topico |
Medical microbiology
Molecular biology Medical Microbiology Molecular Medicine Bacteriòfags Microbiologia mèdica |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-26736-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I: Bacteriophages as antibacterialagents -- Chapter 1:Production of PhageTherapeutics and Formulations – InnovativeApproaches -- Chapter 2:Phagepharmacokinetics: relationship with administrationroute -- Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy -- Part II: Bacteriophages and the immune system -- Chapter 4:Phageinteraction with the mammalianimmune system -- Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics -- Part III:Use of bacteriophages to combat bacterial infections -- Chapter 6:How to achieve a goodphage therapy clinical trial? -- Chapter 7: Perspectives on the RenewedInterest in the United States -- Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections -- Chapter 9:The use of bacteriophages in animalhealth and food protection -- Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria -- Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies -- Part IV:Phage therapy – regulatory and ethical aspects -- Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products -- Chapter 13:Developing phagesintomedicines for Europe -- Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues -- Chapter 15:Ethics of phagetherapy -- Part V: Bacteriophage-derived antibacterial agents -- Chapter 16: NovelAlternative to Antibiotics. |
Record Nr. | UNINA-9910349438503321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|